+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin therapy depresses fat metabolism in older individuals



Statin therapy depresses fat metabolism in older individuals



Journal of the American College of Nutrition 31(1): 32-38



Statins (3-hydroxy-3-methylglutaryl coenzyme A [HMG CoA] reductase inhibitors) reduce blood lipoproteins and reduce the risk of cardiovascular events. However, they may reduce fat metabolism. This study tested the hypothesis that total body fat oxidation is reduced by statins in older subjects and the reduction is not due to substrate availability. A total of 14 elderly patients (71 ± 6 years) on statin therapy were compared with 14 matched elderly controls (75 ± 7 years). Subjects were tested for respiratory exchange ratio (RER) during both maximal and submaximal sustained (70% Vo(2max)) exercise to voluntary exhaustion. Blood samples were drawn for lipoprotein analysis and substrate availability. RER was significantly higher in subjects taking statins during both the max and submax tests, indicating reduced fat oxidation. Blood lipoprotein levels after a fast were not different between the statin and control groups. Levels of glucose, lactate, or triglyceride were not different between groups; however, free fatty acid levels were elevated by exercise in the statin group. Fat oxidation was significantly reduced in older subjects taking statin drugs that were not associated with diet, exercise, and fitness, which were matched between groups, nor availability of fat from the blood, which was higher in the statin group. Although statin therapy normalizes blood lipoproteins, it reduced fat metabolism in older individuals, which cannot be a result of lower availability from blood.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911219

Download citation: RISBibTeXText

PMID: 22661624

DOI: 10.1080/07315724.2012.10720006


Related references

Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation. Journal of Inherited Metabolic Disease 30(3): 388-399, 2007

A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy. Journal of Cardiology 60(1): 12-17, 2013

Premorbid statin use is associated with improved survival and functional outcomes in older head-injured individuals. Journal of Trauma 71(4): 815-819, 2011

A peri-operative statin update for non-cardiac surgery. Part I: The effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia 63(1): 52-64, 2007

Statin-Ezetimibe Combination Therapy In Diabetic Individuals. Angiology 67(6): 507-509, 2015

FDA approves a statin therapy for some: certain, asymptomatic individuals targeted. JAMA 303(13): 1242-1243, 2010

Statin therapy of individuals with high risk for coronary disease. Tidsskrift for den Norske Laegeforening 116(12): 1479-1481, 1996

Statin Therapy and Cognition in Older People: What is the Evidence?. Current Clinical Pharmacology 10(3): 185-193, 2016

Statin therapy may reduce risk of DVT in older persons. Geriatrics 56(8): 18-18, 2001

Statin therapy in older persons: pertinent issues. Archives of Internal Medicine 162(12): 1329-1331, 2002

Rosuvastatin and clinical outcomes in individuals who are not deemed appropriate for baseline statin therapy. Current Atherosclerosis Reports 12(1): 5-7, 2010

Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study. Indian Heart Journal 68(5): 646-654, 2016

Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clinical Cardiology 37(11): 653-659, 2015

Use of statin therapy to reduce cardiovascular risk in older patients. Current Gerontology and Geriatrics Research: 915296-915296, 2010

Very elderly individuals with severe coronary artery disease also benefit from statin therapy. Circulation 104(17 Supplement): II 601, October 23, 2001